Physiological and structural differences in spatially distinct subpopulations of cardiac mitochondria: Influence of cardiac pathologies

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 1, 2014, Pages

  Hollander, John M ^a   Thapa, Dharendra ^a   Shepherd, Danielle L ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Diabetes mellitus; Heart failure; Ischemia reperfusion; Mitochondria

Indexed keywords

CALCIUM; CARVEDILOL; NEBIVOLOL;

AGING; CELL FUNCTION; CELL ORGANELLE; CELL STRUCTURE; EXERCISE; HEART FAILURE; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART STRESS; HUMAN; HYPERMETABOLISM; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; ANIMAL; BIOLOGICAL MODEL; CELL RESPIRATION; CLASSIFICATION; HEART; HEART DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ANIMALS; CELL RESPIRATION; HEART; HEART DISEASES; HUMANS; MITOCHONDRIA, HEART; MODELS, CARDIOVASCULAR; TISSUE DISTRIBUTION;

EID: 84903601098     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00747.2013     Document Type: Review

References (147)

1. Asemu G, O'Connell KA, Cox JW, Dabkowski ER, Xu W, Ribeiro RF Jr,. Shekar KC, Hecker PA, Rastogi S, Sabbah HN, Hoppel CL, and Stanley WC. Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long-term aldosterone infusion. Am J Physiol Heart Circ Physiol 304: H514-H528, 2013.
2. Baseler WA, Dabkowski ER, Jagannathan R, Thapa D, Nichols CE, Shepherd DL, Croston TL, Powell M, Razunguzwa TT, Lewis SE, Schnell DM, Hollander JM. Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. Am J Physiol Regul Integr Comp Physiol 304: R553-R565, 2013.
3. Baseler WA, Dabkowski ER, Williamson CL, Croston TL, Thapa D, Powell MJ, Razunguzwa TT, Hollander JM. Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol 300: R186-R200, 2011.
4. Baseler WA, Thapa D, Jagannathan R, Dabkowski ER, Croston TL, Hollander JM. miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. Am J Physiol Cell Physiol 303: C1244-C1251, 2012.
5. Birkedal R, Shiels HA, Vendelin M. Three-dimensional mitochondrial arrangement in ventricular myocytes: from chaos to order. Am J Physiol Cell Physiol 291: C1148-C1158, 2006.
6. Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, Schulz R. Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol 104: 141-147, 2009.
7. Borutaite V, Brown GC. Mitochondria in apoptosis of ischemic heart. FEBS Lett 541: 1-5, 2003.
8. Cheema Y, Sherrod JN, Zhao W, Zhao T, Ahokas RA, Sun Y, Gerling IC, Bhattacharya SK, Weber KT. Mitochondriocentric pathway to cardiomyocyte necrosis in aldosteronism: cardioprotective responses to carvedilol and nebivolol. J Cardiovasc Pharmacol 58: 80-86, 2011.
9. Chen Q, Hoppel CL, Lesnefsky EJ. Blockade of electron transport before cardiac ischemia with the reversible inhibitor amobarbital protects rat heart mitochondria. J Pharmacol Exp Ther 316: 200-207, 2006.
10. Chen Q, Lesnefsky EJ. Blockade of electron transport during ischemia preserves bcl-2 and inhibits opening of the mitochondrial permeability transition pore. FEBS Lett 585: 921-926, 2011.
11. Chen Q, Lesnefsky EJ. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Radic Biol Med 40: 976-982, 2006.
12. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294: C460-C466, 2008.
13. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. J Pharmacol Exp Ther 319: 1405-1412, 2006.
14. Chen Q, Paillard M, Gomez L, Li H, Hu Y, Lesnefsky EJ. Postconditioning modulates ischemia-damaged mitochondria during reperfusion. J Cardiovasc Pharmacol 59: 101-108, 2012.
15. Chen Q, Ross T, Hu Y, Lesnefsky EJ. Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane. J Aging Res 2012: 753949, 2012.
16. Chen Q, Yin G, Stewart S, Hu Y, Lesnefsky EJ. Isolating the segment of the mitochondrial electron transport chain responsible for mitochondrial damage during cardiac ischemia. Biochem Biophys Res Commun 397: 656-660, 2010.
17. Coleman R, Weiss A, Finkelbrand S, Silbermann M. Age and exercise-related changes in myocardial mitochondria in mice. Acta Histochem 83: 81-90, 1988.
18. Crost S, Martin MK, Palmer JW. Hormonal effects on mitochondrial respiration: potential role of endogenous lipolytic activities. Arch Biochem Biophys 256: 421-429, 1987.
19. Croston TL, Shepherd DL, Thapa D, Nichols CE, Lewis SE, Dabkowski ER, Jagannathan R, Baseler WA, Hollander JM. Evaluation of the cardiolipin biosynthetic pathway and its interactions in the diabetic heart. Life Sci 93: 313-322, 2013.
20. Dabkowski ER, Baseler WA, Williamson CL, Powell M, Razunguzwa TT, Frisbee JC, Hollander JM. Mitochondrial dysfunction in the type 2 diabetic heart is associated with alterations in spatially distinct mitochondrial proteomes. Am J Physiol Heart Circ Physiol 299: H529-H540, 2010.
21. Dabkowski ER, Williamson CL, Bukowski VC, Chapman RS, Leonard SS, Peer CJ, Callery PS, Hollander JM. Diabetic cardiomyopathyassociated dysfunction in spatially distinct mitochondrial subpopulations. Am J Physiol Heart Circ Physiol 296: H359-H369, 2009.
22. Dabkowski ER, Williamson CL, Hollander JM. Mitochondria-specific transgenic overexpression of phospholipid hydroperoxide glutathione peroxidase (GPx4) attenuates ischemia/reperfusion-associated cardiac dysfunction. Free Radic Biol Med 45: 855-865, 2008.
23. Dai DF, Rabinovitch PS, Ungvari Z. Mitochondria and cardiovascular aging. Circ Res 110: 1109-1124, 2012.
24. Dalen H. An ultrastructural study of the hypertrophied human papillary muscle cell with special emphasis on specific staining patterns, mitochondrial projections and association between mitochondria and SR. Virchows Arch A Pathol Anat Histopathol 414: 187-198, 1989.
25. Duan J, Karmazyn M. A rapid phosphate-induced depression of heart subsarcolemmal mitochondrial oxidative phosphorylation. Res Commun Chem Pathol Pharmacol 63: 361-372, 1989.
26. Duan JM, Karmazyn M. Acute effects of hypoxia and phosphate on two populations of heart mitochondria. Mol Cell Biochem 90: 47-56, 1989.
27. Duan JM, Karmazyn M. Effect of verapamil on phosphate-induced changes in oxidative phosphorylation and atractyloside-sensitive adenine nucleotide translocase activity in two populations of rat heart mitochondria. Biochem Pharmacol 38: 3873-3878, 1989.
28. Duan JM, Karmazyn M. Protection of the reperfused ischemic isolated rat heart by phosphatidylcholine. J Cardiovasc Pharmacol 15: 163-171, 1990.
29. Duan JM, Karmazyn M. Reduction of phosphate-induced dysfunction in rat heart mitochondria by carnitine. Eur J Pharmacol 189: 163-174, 1990.
30. Duan JM, Karmazyn M. Relationship between oxidative-phosphorylation and adenine-nucleotide translocase activity of 2 populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 67: 704-709, 1989.
31. + channels in cardiac mitochondria. Life Sci 92: 664-668, 2013.
32. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372: 399-407, 1999.
33. Fawcett DW, McNutt NS. The ultrastructure of the cat myocardium. I. Ventricular papillary muscle. J Cell Biol 42: 1-45, 1969.
34. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med 5: 409-419, 1988.
35. Fujioka H, Moghaddas S, Murdock DG, Lesnefsky EJ, Tandler B, Hoppel CL. Decreased cytochrome c oxidase subunit VIIa in aged rat heart mitochondria: immunocytochemistry. Anat Rec (Hoboken) 294: 1825-1833, 2011.
36. Gallitelli MF, Schultz M, Isenberg G, Rudolf F. Twitch-potentiation increases calcium in peripheral more than in central mitochondria of guinea-pig ventricular myocytes. J Physiol 518: 433-447, 1999.
37. Galvao TF, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 93: 24-32, 2012.
38. Galvao TF, Khairallah RJ, Dabkowski ER, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN, Rastogi S, Daneault C, Des Rosiers C, Stanley WC. Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival. Am J Physiol Heart Circ Physiol 304: H12-H21, 2013.
39. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105-111, 1974.
40. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol 551: 491-501, 2003.
41. Gladden JD, Zelickson BR, Wei CC, Ulasova E, Zheng J, Ahmed MI, Chen Y, Bamman M, Ballinger S, Darley-Usmar V, Dell'Italia LJ. Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload. Free Radic Biol Med 51: 1975-1984, 2011.
42. Gomez LA, Heath SH, Hagen TM. Acetyl-L-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the Lcarnitine content in the rat heart. Mech Ageing Dev 133: 99-106, 2012.
43. Gustafsson R, Tata JR, Lindberg O, Ernster L. The relationship between the structure and activity of rat skeletal muscle mitochondria after thyroidectomy and thyroid hormone treatment. J Cell Biol 26: 555-578, 1965.
44. Heather LC, Carr CA, Stuckey DJ, Pope S, Morten KJ, Carter EE, Edwards LM, Clarke K. Critical role of complex III in the early metabolic changes following myocardial infarction. Cardiovasc Res 85: 127-136, 2010.
45. Heather LC, Cole MA, Tan JJ, Ambrose LJ, Pope S, Abd-Jamil AH, Carter EE, Dodd MS, Yeoh KK, Schofield CJ, Clarke K. Metabolic adaptation to chronic hypoxia in cardiac mitochondria. Basic Res Cardiol 107: 268, 2012.
46. Herpin P, Barre H. Loose-coupled subsarcolemmal mitochondria from muscle Rhomboideus in cold-acclimated piglets. Comp Biochem Physiol B 92: 59-65, 1989.
47. Hoene M, Lehmann R, Hennige AM, Pohl AK, Haring HU, Schleicher ED, Weigert C. Acute regulation of metabolic genes and insulin receptor substrates in the liver of mice by one single bout of treadmill exercise. J Physiol 587: 241-252, 2009.
48. Hofer T, Servais S, Seo AY, Marzetti E, Hiona A, Upadhyay SJ, Wohlgemuth SE, Leeuwenburgh C. Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: effects of aging and lifelong calorie restriction. Mech Ageing Dev 130: 297-307, 2009.
49. Hollander JM, Baseler WA, Dabkowski ER. Proteomic remodeling of mitochondria in heart failure. Congest Heart Fail 17: 262-268, 2011.
50. Hollander JM, Lin KM, Scott BT, Dillmann WH. Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Radic Biol Med 35: 742-751, 2003.
51. Holloszy JO. Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242: 2278-2282, 1967.
52. Holmuhamedov EL, Oberlin A, Short K, Terzic A, Jahangir A. Cardiac subsarcolemmal and interfibrillar mitochondria display distinct responsiveness to protection by diazoxide. PLos One 7: e44667, 2012.
53. Hoppel CL, Moghaddas S, Lesnefsky EJ. Interfibrillar cardiac mitochondrial comples III defects in the aging rat heart. Biogerontology 3: 41-44, 2002.
54. Hoppel CL, Tandler B, Parland W, Turkaly JS, Albers Hamster cardiomyopathy LD. A defect in oxidative phosphorylation in the cardiac interfibrillar mitochondria. J Biol Chem 257: 1540-1548, 1982.
55. Jones M, Ferrans VJ, Morrow AG, Roberts WC. Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstruction. Circulation 51: 39-67, 1975.
56. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Ageassociated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 19: 419-421, 2005.
57. Judge S, Jang YM, Smith A, Selman C, Phillips T, Speakman JR, Hagen T, Leeuwenburgh C. Exercise by lifelong voluntary wheel running reduces subsarcolemmal and interfibrillar mitochondrial hydrogen peroxide production in the heart. Am J Physiol Regul Integr Comp Physiol 289: R1564-R1572, 2005.
58. Jullig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ, Costa S, Choong SY, Philips AR, Cooper GJ. Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics 8: 2556-2572, 2008.
59. Kaasik A, Veksler V, Boehm E, Novotova M, Minajeva A, Ventura-Clapier R. Energetic crosstalk between organelles: architectural integration of energy production and utilization. Circ Res 89: 153-159, 2001.
60. Kann O, Kovacs R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292: C641-C657, 2007.
61. Kasumov T, Dabkowski ER, Shekar KC, Li L, Ribeiro RF Jr, Walsh K, Previs SF, Sadygov RG, Willard B, Stanley WC. Assessment of cardiac proteome dynamics with heavy water: slower protein synthesis rates in interfibrillar than subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 304: H1201-H1214, 2013.
62. Katz AM. Physiology of the Heart. Philadelphia: Lippincott Williams and Wilkins, 2006.
63. Kavazis AN, Alvarez S, Talbert E, Lee Y, Powers SK. Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins. Am J Physiol Heart Circ Physiol 297: H144-H152, 2009.
64. Kavazis AN, McClung JM, Hood DA, Powers SK. Exercise induces a cardiac mitochondrial phenotype that resists apoptotic stimuli. Am J Physiol Heart Circ Physiol 294: H928-H935, 2008.
65. Kubista V, Kubistova J, Pette D. Thyroid hormone induced changes in the enzyme activity pattern of energy-supplying metabolism of fast (white), slow (red), and heart muscle of the rat. Eur J Biochem 18: 553-560, 1971.
66. Kuznetsov AV, Troppmair J, Sucher R, Hermann M, Saks V, Margreiter R. Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: possible physiological role? Biochim Biophys Acta 1757: 686-691, 2006.
67. Lee Y, Min K, Talbert EE, Kavazis AN, Smuder AJ, Willis WT, Powers SK. Exercise protects cardiac mitochondria against ischemiareperfusion injury. Med Sci Sports Exerc 44: 397-405, 2012.
68. Lemieux H, Vazquez EJ, Fujioka H, Hoppel CL. Decrease in mitochondrial function in rat cardiac permeabilized fibers correlates with the aging phenotype. J Gerontol A Biol Sci Med Sci 65: 1157-1164, 2010.
69. Lesnefsky EJ, Chen Q, Moghaddas S, Hassan MO, Tandler B, Hoppel CL. Blockade of electron transport during ischemia protects cardiac mitochondria. J Biol Chem 279: 47961-47967, 2004.
70. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MSK, Minkler PE, Hassan MO, Tandler B, Hoppel CL. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258-H267, 2004.
71. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, Hoppel CL. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385: 117-128, 2001.
72. Lesnefsky EJ, Gudz TI, Moghaddas S, Migita CT, Ikeda-Saito M, Turkaly PJ, Hoppel CL. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol 33: 37-47, 2001.
73. Lesnefsky EJ, He D, Moghaddas S, Hoppel CL. Reversal of mitochondrial defects before ischemia protects the aged heart. FASEB J 20: 1543-1545, 2006.
74. Lesnefsky EJ, Hoppel CL. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim Biophys Acta 1777: 1020-1027, 2008.
75. Lesnefsky EJ, Minkler P, Hoppel CL. Enhanced modification of cardiolipin during ischemia in the aged heart. J Mol Cell Cardiol 46: 1008-1015, 2009.
76. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 33: 1065-1089, 2001.
77. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 280: H2770-H2778, 2001.
78. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 273: H1544-H1554, 1997.
79. 2+ signaling. Int J Biochem Cell Biol 41: 1957-1971, 2009.
80. Lukyanenko V, Ziman A, Lukyanenko A, Salnikov V, Lederer WJ. Functional groups of ryanodine receptors in rat ventricular cells. J Physiol 583: 251-269, 2007.
81. Matlib MA, Rebman D, Ashraf M, Rouslin W, Schwartz A. Differential activities of putative subsarcolemmal and interfibrillar mitochondria from cardiac muscle. J Mol Cell Cardiol 13: 163-170, 1981.
82. Mayer LR, Bonner HW, Farrar RP. Myocardial mitochondrial synthesis in response to various workloads. Res Commun Chem Pathol Pharmacol 34: 157-160, 1981.
83. McCallister BD, Brown AL Jr. A quantitative study of myocardial mitochondria in experimental cardiac hypertrophy. Ann N Y Acad Sci 156: 469-479, 1969.
84. McKean TA. Comparison of respiration in rat, guinea pig and muskrat heart mitochondria. Comp Biochem Physiol B 97: 109-112, 1990.
85. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 150: 1283-1298, 2000.
86. Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys 414: 59-66, 2003.
87. Moghaddas S, Stoll MS, Minkler PE, Salomon RG, Hoppel CL, Lesnefsky EJ. Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria. J Gerontol A Biol Sci Med Sci 57: B22-B28, 2002.
88. Monette JS, Gomez LA, Moreau RF, Bemer BA, Taylor AW, Hagen TM. Characteristics of the rat cardiac sphingolipid pool in two mitochondrial subpopulations. Biochem Biophys Res Commun 398: 272-277, 2010.
89. Muller W. Subsarcolemmal mitochondria and capillarization of soleus muscle fibers in young rats subjected to an endurance training. A morphometric study of semithin sections. Cell Tissue Res 174: 367-389, 1976.
90. Nielsen J, Mogensen M, Vind BF, Sahlin K, Hojlund K, Schroder HD, Ortenblad N. Increased subsarcolemmal lipids in type 2 diabetes: effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab 298: E706-E713, 2010.
91. Nishiki K, Erecinska M, Wilson DF, Cooper S. Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats. Am J Physiol Cell Physiol 235: C212-C219, 1978.
92. 2+-induced permeability transition. J Mol Cell Cardiol 47: 819-827, 2009.
93. Padrao AI, Ferreira RM, Vitorino R, Alves RM, Neuparth MJ, Duarte JA, Amado F. OXPHOS susceptibility to oxidative modifications: the role of heart mitochondrial subcellular location. Biochim Biophys Acta 1807: 1106-1113, 2011.
94. Paillard M, Gomez L, Augeul L, Loufouat J, Lesnefsky EJ, Ovize M. Postconditioning inhibits mPTP opening independent of oxidative phosphorylation and membrane potential. J Mol Cell Cardiol 46: 902-909, 2009.
95. Palmer JW, Tandler B, Hoppel CL. Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: effects of procedural manipulations. Arch Biochem Biophys 236: 691-702, 1985.
96. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731-8739, 1977.
97. Palmer JW, Tandler B, Hoppel CL. Heterogeneous response of subsarcolemmal heart mitochondria to calcium. Am J Physiol Heart Circ Physiol 250: H741-H748, 1986.
98. Pande SV, Blanchaer MC. Preferential loss of ATP-dependent longchain fatty acid activating enzyme in mitochondria prepared using Nagarse. Biochim Biophys Acta 202: 43-48, 1970.
99. Papanicolaou KN, Ngoh GA, Dabkowski ER, O'Connell KA, Ribeiro RF Jr, Stanley WC, Walsh K. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROSinduced mitochondrial dysfunction and cell death. Am J Physiol Heart Circ Physiol 302: H167-H179, 2012.
100. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases American Heart Association Science Advisory and Coordinating Committee. Circulation 106: 388-391, 2002.
101. Picard M, White K, Turnbull DM. Mitochondrial morphology, topology, and membrane interactions in skeletal muscle: a quantitative threedimensional electron microscopy study. J Appl Physiol (1985) 114: 161-171, 2013.
102. Piot C, Hocquette JF, Herpin P, Veerkamp JH, Bauchart D. Dietary coconut oil affects more lipoprotein lipase activity than the mitochondria oxidative capacities in muscles of preruminant calves. J Nutr Biochem 11: 231-238, 2000.
103. Qian LP, Zhu SS, Cao JL, Zeng YM. Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts. Acta Pharmacol Sin 26: 813-820, 2005.
104. Rennison JH, McElfresh TA, Chen X, Anand VR, Hoit BD, Hoppel CL, Chandler MP. Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol 46: 883-890, 2009.
105. Rennison JH, McElfresh TA, Okere IC, Patel HV, Foster AB, Patel KK, Stoll MS, Minkler PE, Fujioka H, Hoit BD, Young ME, Hoppel CL, Chandler MP. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 79: 331-340, 2008.
106. Rennison JH, McElfresh TA, Okere IC, Vazquez EJ, Patel HV, Foster AB, Patel KK, Chen Q, Hoit BD, Tserng KY, Hassan MO, Hoppel CL, Chandler MP. High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol 292: H1498-H1506, 2007.
107. Riva A, Tandler B, Lesnefsky EJ, Conti G, Loffredo F, Vazquez E, Hoppel CL. Structure of cristae in cardiac mitochondria of aged rat. Mech Ageing Dev 127: 917-921, 2006.
108. Riva A, Tandler B, Loffredo F, Vazquez E, Hoppel C. Structural differences in two biochemically defined populations of cardiac mitochondria. Am J Physiol Heart Circ Physiol 289: H868-H872, 2005.
109. Rosca M, Minkler P, Hoppel CL. Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim Biophys Acta 1807: 1373-1382, 2011.
110. Rosca MG, Hoppel CL. Mitochondria in heart failure. Cardiovasc Res 88: 40-50, 2010.
111. Rosca MG, Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev 18: 607-622, 2013.
112. Rosca MG, Vazquez EJ, Kerner J, Parland W, Chandler MP, Stanley W, Sabbah HN, Hoppel CL. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res 80: 30-39, 2008.
113. Salnikov V, Lukyanenko YO, Lederer WJ, Lukyanenko V. Distribution of ryanodine receptors in rat ventricular myocytes. J Muscle Res Cell Motil 30: 161-170, 2009.
114. Scheffler IE. Mitochondria. New Jersey: Wiley-Liss, 2008.
115. Schwarzer M, Schrepper A, Amorim PA, Osterholt M, Doenst T. Pressure overload differentially affects respiratory capacity in interfibrillar and subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 304: H529-H537, 2013.
116. Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, Zani M, Feccia M, Mancini M, Petrozza V, Cossarizza A, Gallo P, Taylor RW, d'Amati G. Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol 50: 1362-1369, 2007.
117. Severson DL. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82: 813-823, 2004.
118. Shimada T, Horita K, Murakami M, Ogura R. Morphological studies of different mitochondrial populations in monkey myocardial cells. Cell Tissue Res 238: 577-582, 1984.
119. Shin G, Sugiyama M, Shoji T, Kagiyama A, Sato H, Ogura R. Detection of mitochondrial membrane damages in myocardial ischemia with ESR spin labeling technique. J Mol Cell Cardiol 21: 1029-1036, 1989.
120. Siddiq T, Salisbury JR, Richardson PJ, Preedy VR. Synthesis of ventricular mitochondrial proteins in vivo: effect of acute ethanol toxicity. Alcohol Clin Exp Res 17: 894-899, 1993.
121. Sillau AH, Ernst V, Reyes N. Oxidative capacity distribution in the cardiac myocytes of hypermetabolic rats. Respir Physiol 79: 279-291, 1990.
122. Skulachev VP. Mitochondrial filaments and clusters as intracellular power-transmitting cables. Trends Biochem Sci 26: 23-29, 2001.
123. Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390: 377-394, 2005.
124. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML, Maxey ML, McCune SA, Moore RL. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 48: 1559-1570, 2007.
125. Stallknecht B, Vinten J, Ploug T, Galbo H. Increased activities of mitochondrial enzymes in white adipose tissue in trained rats. Am J Physiol Endocrinol Metab 261: E410-E414, 1991.
126. Stewart S, Lesnefsky EJ, Chen Q. Reversible blockade of electron transport with amobarbital at the onset of reperfusion attenuates cardiac injury. Transl Res 153: 224-231, 2009.
127. Suh JH, Heath SH, Hagen TM. Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med 35: 1064-1072, 2003.
128. Sutherland LN, Bomhof MR, Capozzi LC, Basaraba SA, Wright DC. Exercise and adrenaline increase PGC-1α mRNA expression in rat adipose tissue. J Physiol 587: 1607-1617, 2009.
129. 2 gradients in a single cardiomyocyte of the rat. Am J Physiol Heart Circ Physiol 275: H225-H233, 1998.
130. Tandler B, Dunlap M, Hoppel CL, Hassan M. Giant mitochondria in a cardiomyopathic heart. Ultrastruct Pathol 26: 177-183, 2002.
131. Tandler B, Hoppel CL. Possible division of cardiac mitochondria. Anat Rec 173: 309-323, 1972.
132. Tanne Z, Coleman R, Nahir M, Shomrat D, Finberg JP, Youdim MB. Ultrastructural and cytochemical changes in the heart of irondeficient rats. Biochem Pharmacol 47: 1759-1766, 1994.
133. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107: 3109-3116, 2003.
134. Troyer D, Cash W, Leipold H. Skeletal muscle of cattle affected with progressive degenerative myeloencephalopathy. Am J Vet Res 54: 1084-1087, 1993.
135. Ulasova E, Gladden JD, Chen Y, Zheng J, Pat B, Bradley W, Powell P, Zmijewski JW, Zelickson BR, Ballinger SW, Darley-Usmar V, Dell'italia LJ. Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload. J Mol Cell Cardiol 50: 147-156, 2011.
136. van Empel VP, Bertrand AT, van der Nagel R, Kostin S, Doevendans PA, Crijns HJ, de Wit E, Sluiter W, Ackerman SL, De Windt LJ. Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res 96: e92-e101, 2005.
137. Vergeade A, Mulder P, Vendeville-Dehaudt C, Estour F, Fortin D, Ventura-Clapier R, Thuillez C, Monteil C. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ. Free Radic Biol Med 49: 748-756, 2010.
138. Vergeade A, Mulder P, Vendeville C, Ventura-Clapier R, Thuillez C, Monteil C. Xanthine oxidase contributes to mitochondrial ROS generation in an experimental model of cocaine-induced diastolic dysfunction. J Cardiovasc Pharmacol 60: 538-543, 2012.
139. Weinstein ES, Benson DW, Fry DE. Subpopulations of human heart mitochondria. J Surg Res 40: 495-498, 1986.
140. Weinstein ES, Benson DW, Ratcliffe DJ, Maksem J, Fry DE. Experimental myocardial ischemia. Differential injury of mitochondrial subpopulations. Arch Surg 120: 332-338, 1985.
141. Weinstein ES, Hampton WW, Yokum MD, Fry DE. Isovolemic hemodilution: correlations of mitochondrial and myocardial performance. J Trauma 26: 620-624, 1986.
142. Weinstein ES, Spector ML, Adams EM, Yokum MD, Humphrey RW, Fry DE. Mitochondrial and myocardial performance. Response to ischemia and reperfusion. Arch Surg 121: 324-329, 1986.
143. Williamson CL, Dabkowski ER, Baseler WA, Croston TL, Alway SE, Hollander JM. Enhanced apoptotic propensity in diabetic cardiac mitochondria: influence of subcellular spatial location. Am J Physiol Heart Circ Physiol 298: H633-H642, 2010.
144. Wojtovich AP, Nadtochiy SM, Brookes PS, Nehrke K. Ischemic preconditioning: the role of mitochondria and aging. Exp Gerontol 47: 1-7, 2012.
145. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 118: 1000-1012, 1989.
146. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.
147. Zhou L, O'Rourke B. Cardiac mitochondrial network excitability: insights from computational analysis. Am J Physiol Heart Circ Physiol 302: H2178-H2189, 2012.